Compare Tenet Healthcare Corporation (THC) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Vir Biotechnology Inc. Common Stock — how do they compare? Tenet Healthcare Corporation trades at $274.21 (market cap $21.87B), while Vir Biotechnology Inc. Common Stock trades at $10.51 (market cap $1.76B). The key difference: Tenet Healthcare Corporation is far larger — about 12.4× Vir Biotechnology Inc. Common Stock's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Vir Biotechnology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 16 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| THC | VIR | |
|---|---|---|
Market Cap | $21.87B | $1.76B |
Volume | 717,275 | 2,764,948 |
Sector | Health | Health |
52-Week High | $280.77 | $11.78 |
52-Week Low | $161.37 | $5.12 |
Typical Hold Time | 16 Days | 0 Days |
Enterprise Value | $32.95B | $1.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $274.99, up 3.03% with strong bullish momentum. The stock shows robust fundamentals with a P/E of 10.5, net income margin of 9.9%, and consistent earnings beats. Technical indicators signal bullish sentiment with moving averages supporting upward momentum, though RSI levels suggest potential overbought conditions. Recent news highlights strong cash flow supporting capital return strategies and upcoming Q3 2026 earnings release on October 29.
THC presents compelling value with attractive valuation multiples and strong profitability metrics. The primary opportunity lies in continued earnings growth and shareholder returns, while risks include sustainability of cash flow for capital allocation and potential market volatility near technical resistance levels. Analyst consensus remains strongly bullish with 81% buy ratings and $283.36 price target.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
